Hasan, Alkomiet 1982-
Alkomiet Hasan
VIAF ID: 81819282 ( Personal )
Permalink: http://viaf.org/viaf/81819282
Preferred Forms
- 100 0 _ ‡a Alkomiet Hasan
- 100 1 _ ‡a Hasan, Alkomiet ‡d 1982-
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations | |
Bidirectional variability in motor cortex excitability modulation following 1 mA transcranial direct current stimulation in healthy participants | |
Cerebrospinal fluid pathologies in schizophrenia-spectrum disorder: a retrospective chart review | |
Characterizing cognitive subtypes in schizophrenia using cortical curvature | |
Clinical manifestations and immunomodulatory treatment experiences in psychiatric patients with suspected autoimmune encephalitis: a case series of 91 patients from Germany | |
Clozapine-induced gastrointestinal hypomotility: new objective evidence for an underestimated side-effect | |
Clozapine optimization: a Delphi consensus guideline from the Treatment Response and Resistance in Psychosis Working Group | |
co-localisation with specific neurotransmitter systems discriminates schizophrenia patients from healthy controls [Abstract] | |
Cognitive and emotional empathy in individuals at clinical high risk of psychosis | |
Cognitive and functional deficits are associated with white matter abnormalities in two independent cohorts of patients with schizophrenia | |
Comparative study of a continuous train of theta-burst stimulation for a duration of 20 s (cTBS 300) versus a duration of 40 s (cTBS 600) in a pre-stimulation relaxed condition in healthy volunteers | |
Comparative study of motor cortical excitability changes following anodal tDCS or high‐frequency tRNS in relation to stimulation duration | |
Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions | |
Compromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic α4β2-receptor partial agonist varenicline | |
Concept of the Munich/Augsburg Consortium Precision in Mental Health for the German Center of Mental Health | |
Decreased serum brain-derived neurotrophic factor concentrations 72 hours following marathon running | |
Effectiveness and cost-effectiveness for the treatment of depressive symptoms in refugees and asylum seekers: a multi-centred randomized controlled trial | |
Effects of exercise in people with severe mental illness and recommendations for its implementation as add-on therapy [Abstract] | |
Effects of high-frequency prefrontal rTMS on heart frequency rates and blood pressure in schizophrenia | |
Effects of nicotine intake on neuroplasticity in smoking and non-smoking patients with schizophrenia | |
Effects of three months of aerobic endurance training on motor cortical excitability in schizophrenia patients and healthy subjects | |
Efficacy and safety of clozapine in psychotic disorders: a systematic quantitative meta-review | |
Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST) | |
EPA-1507 - Cortical inhibition in schizophrenia: a retrospective pooled cross-sectional analysis [Abstract] | |
Exercise addiction measured at a naturalistic marathon-event – associations of the EAI with the general level of functioning, affect and performance parameters | |
Exercise as an add-on treatment in individuals with schizophrenia: results from a large multicenter randomized controlled trial | |
Exploring effects of exercise on the functional connectome in patients with schizophrenia [Abstract] | |
F107. CSF abnormalities in schizophrenia and depression: preliminary results from a large scale cohort | |
Fitness is positively associated with hippocampal formation subfield volumes in schizophrenia: a multiparametric magnetic resonance imaging study | |
Grundlagen gestörter kortikaler Plastizität, Exzitabilität und Konnektivität bei schizophrenen Psychosen : kumulative Habilitationsschrift | |
Guideline for schizophrenia: implementation status and attitude toward an upcoming living guideline | |
High-mobility group box 1 protein, receptor for advanced glycation end products and nucleosomes increases after marathon | |
A house is not a home: a network model perspective on the dynamics between subjective quality of living conditions, social support, and mental health of refugees and asylum seekers | |
How to reduce mental health burden in health care workers during COVID-19? A scoping review of guideline recommendations | |
impact of environmental factors in severe psychiatric disorders | |
Impact of smoking behavior on clozapine blood levels: a systematic review and meta‐analysis | |
An international research agenda for clozapine-resistant schizophrenia | |
Kortikale Hypoexzitabilität und cholinerge Aktivierung nach chronischem Zigarettenkonsum | |
Lethal lust: suicidal behavior and chemsex — a narrative review of the literature | |
Marathon running improves mood and negative affect | |
Medication adherence in a cross-diagnostic sample of patients from the affective-to-psychotic spectrum: results from the PsyCourse study | |
Motor-cortex excitability and response variability following paired-associative stimulation: a proof-of-concept study comparing individualized and fixed inter-stimulus intervals | |
Multiband fractional amplitude of low-frequency fluctuations predicts social functioning transdiagnostically in the clinical high-risk for psychosis state and recent-onset depression [Abstract] | |
multimodal Munich Clinical Deep Phenotyping study to bridge the translational gap in severe mental illness treatment research | |
Muscle and timing-specific functional connectivity between the dorsolateral prefrontal cortex and the primary motor cortex | |
Nonpharmacological treatment of dyscognition in schizophrenia: effects of aerobic exercise | |
Oligodendrocyte and interneuron density in hippocampal subfields in schizophrenia and association of oligodendrocyte number with cognitive deficits | |
Parameter-based evaluation of attentional impairments in schizophrenia and their modulation by prefrontal transcranial direct current stimulation | |
Personality traits in marathon runners and sedentary controls with MMPI-2-RF | |
Polygenic risk has an impact on the structural plasticity of hippocampal subfields during aerobic exercise combined with cognitive remediation in multi-episode schizophrenia | |
Praxishandbuch Schizophrenie Diagnostik – Therapie – Versorgungsstrukturen | |
Predictors of competitive employment in individuals with severe mental illness: results from an observational, cross-sectional study in Germany | |
Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial | |
relationship between blood–brain barrier dysfunction and neurocognitive impairments in first-episode psychosis: findings from a retrospective chart analysis | |
Repositioning synthetic glucocorticoids in psychiatric disease associated with neural autoantibodies: a narrative review | |
Resistance training in patients with schizophrenia: concept and proof of principle trial | |
role of migration in mental healthcare: treatment satisfaction and utilization | |
rTMS and tDCS for the treatment of catatonia: a systematic review | |
Running effects on cognition and plasticity (ReCaP): study protocol of a longitudinal examination of multimodal adaptations of marathon running | |
S207. TDCS as future treatment option for schizophrenia patients: a neurophysiological investigation of induced plasticity over motor and prefrontal cortex using sloreta | |
S231. The role of dopaminergic and glutamatergic neurotransmission in delusional ideation and sensory information processing of patients with schizophrenia in comparison to healthy human participants | |
S47. Add-on spironolactone for the treatment of schizophrenia (spiro treat) | |
S49. Efficacy of high-frequency repetitive transcranial magnetic stimulation on panss factors in schizophrenia with predominant negative symptoms: results from an exploratory re-analysis | |
S79. Enhancing working memory in schizophrenia using 1ma and 2ma transcranial direct stimulation to the left dorsolateral prefrontal cortex | |
Safety of repeated twice-daily 30 minutes of 2 mA tDCS in depressed patients | |
Shared sorrow, shared costs: cost-effectiveness analysis of the Empowerment group therapy approach to treat affective disorders in refugee populations | |
Smoking and quality of life in lung cancer patients: systematic review | |
Spironolactone alleviates schizophrenia-related reversal learning in Tcf4 transgenic mice subjected to social defeat | |
Stimulation transcrânienne par courant continu (TDCS) en psychiatrie: une mise à jour en 2017 | |
Structural alterations in psychotic disorders co-localize with serotonergic and dopaminergic neurotransmitter systems [Abstract] | |
Structured implementation of digital, systematically updated guideline recommendations for enhanced adherence in schizophrenia (SISYPHOS) — protocol of a cluster-randomized trial | |
Studienkonzept: Sexarbeit unter Chemsex-Usern (SEARCHER) [Abstract] | |
Subjective burden and perspectives of German healthcare workers during the COVID-19 pandemic | |
Supporting return to work after psychiatric hospitalization — a cluster randomized study (RETURN-study) | |
A systematic review of trials investigating strength training in schizophrenia spectrum disorders | |
Transcranial direct current stimulation (tDCS) for major depression – interim analysis of cloud supervised technical data from the DepressionDC trial | |
transformation of masculinity orientations and work-related attitudes in men treated for depression (TRANSMODE): study protocol for a mixed-methods observational study | |
Transkranielle elektrische Hirnstimulationsverfahren zur Behandlung der Negativsymptomatik bei Schizophrenie | |
Treatment-resistant schizophrenia and global cortical atrophy in a patient with Turner Syndrome [Letter] | |
Zur Identität der Psychiatrie: Positionspapier einer DGPPN-Task-Force zum Thema Identität |